Lerer Kenneth B's Form 4 filing
Strata Critical Medical, Inc. (SRTA) · filed May 27, 2022
- Accession no.
- 0000899243-22-019994
- Filed
- May 27, 2022
- Trade date
- May 25-26, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $3.31M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lerer Kenneth BCIK 0001120789 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 25, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −3,931 | $7.11F1 | −$27,949.41 | 103,455 | Direct | |
| May 25, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −8,602 | $7.11F1 | −$61,160.22 | 102,898 | Indirect | |
| May 25, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −53,916 | $7.11F1 | −$383,342.76 | 644,985 | Indirect | |
| May 25, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −28,851 | $7.11F1 | −$205,130.61 | 345,137 | Indirect | |
| May 26, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −47,029 | $7.03F6 | −$330,613.87 | 56,426 | Direct | |
| May 25, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −102,898 | $7.03F6 | −$723,372.94 | 0 | Indirect | |
| May 26, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −146,873 | $7.01F7 | −$1,029,579.73 | 498,112 | Indirect | |
| May 26, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −78,593 | $7.01F7 | −$550,936.93 | 266,544 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These transactions were executed in multiple trades at prices ranging from $7.01 to $7.21, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 4 transactions in Table I.
- F6
These transactions were executed in multiple trades at prices ranging from $7.00 to $7.20, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 2 transactions in Table I.
- F7
These transactions were executed in multiple trades at prices ranging from $6.915 to $7.240, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 2 transactions in Table I.